Aclaris Therapeutics Share Price Today (NASDAQ: ACRS)
Aclaris Therapeutics share price is 1.31 & ₹111.87 as on 20 May 2025, 2.30 'hrs' IST
$1.31
Market is closed - opens 7 PM, 20 May 2025
View live Aclaris Therapeutics share price in Dollar and Rupees. Guide to invest in Aclaris Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aclaris Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Aclaris Therapeutics share price movements
- Today's Low: $1.28Today's High: $1.33
2.67%
Downside
Day's Volatility :4.14%
Upside
1.5%
- 52 Weeks Low: $0.9552 Weeks High: $5.17
27.37%
Downside
52 Weeks Volatility :81.6%
Upside
74.66%
Aclaris Therapeutics (ACRS) Returns
Aclaris Therapeutics (ACRS) Key Statistics
in dollars & INR
How to invest in Aclaris Therapeutics Stock (ACRS) from India?
It is very easy for Indian residents to invest directly in Aclaris Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aclaris Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aclaris Therapeutics or ACRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aclaris Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Aclaris Therapeutics shares which would translate to 0.652 fractional shares of Aclaris Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Aclaris Therapeutics, in just a few clicks!
Returns in Aclaris Therapeutics (ACRS) for Indian investors in Rupees
The Aclaris Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Aclaris Therapeutics investment value today
Current value as on today
₹1,12,632
Returns
₹12,632
(+12.63%)
Returns from Aclaris Therapeutics Stock
₹10,084 (+10.08%)
Dollar Returns
₹2,548 (+2.55%)
Indian investors sentiment towards Aclaris Therapeutics (ACRS)
Global Institutional Holdings in Aclaris Therapeutics
BML Capital Management LLC
13.16%
Adage Capital Partners Gp LLC
8.89%
Vivo Capital, LLC
8.21%
Rock Springs Capital Management LP
5.73%
Vanguard Group Inc
4.59%
RA Capital Management, LLC
4.31%
Analyst Recommendation on Aclaris Therapeutics
Hold
40%Buy
60%Hold
0%Sell
Based on 15 Wall street analysts offering stock ratings for Aclaris Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Aclaris Therapeutics Stock (ACRS)
What analysts predicted
Upside of 525.95%
Target:
$8.20
Current:
$1.31
Insights on Aclaris Therapeutics Stock (Ticker Symbol: ACRS)
Price Movement
In the last 7 days, ACRS stock has moved up by 7.0%Decreasing Revenue
Revenue is down for the last 2 quarters, 9.21M → 1.45M (in $), with an average decrease of 84.2% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -96.55M → -15.08M (in $), with an average increase of 540.1% per quarterACRS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 94.2% return, outperforming this stock by 84.5%ACRS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.6% return, outperforming this stock by 209.8%Price to Sales
ForACRS every $1 of sales, investors are willing to pay $6.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.0 for every $1 of sales.
Aclaris Therapeutics Technicals Summary
Sell
Neutral
Buy
Aclaris Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Aclaris Therapeutics (ACRS) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 15.49% | -71.57% | 9.66% | -89.35% | 5.24% |
 | 5.81% | -20.13% | -39.76% | -12.79% | 6.01% |
 | 1.64% | 24.08% | 33.65% | 72.36% | 41.54% |
 | -8.14% | -1.66% | -1.19% | 64.18% | 54.79% |
 | 22.5% | 24.54% | 94.2% | 125.17% | 105.67% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | -0.13 | -0.58 | -0.84 | -0.16 | NA | 1.44 |
| 15.11 | 15.11 | 1.28 | 35.5 | 0.16 | 0.07 | 0.01 | 277.5 |
| NA | NA | NA | 1.5 | -0.11 | -0.03 | NA | 32.42 |
| 32.84 | NA | 2.61 | 18.0 | -0.06 | 0.12 | NA | 64.2 |
| NA | NA | -0.49 | 1.01 | -15.01 | -0.02 | NA | 0.89 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Hold | $141.8M | 5.24% | NA | 0.0% |
| Buy | $64.2B | 6.01% | 15.11 | 31.94% |
| NA | $26.3B | 41.54% | NA | -9.4% |
| Buy | $112.6B | 54.79% | 32.84 | -8.91% |
| Buy | $37.2B | 105.67% | NA | -11.49% |
About Aclaris Therapeutics
Management People of Aclaris Therapeutics
Important FAQs about investing in ACRS Stock from India :
Can Indians buy Aclaris Therapeutics shares?
Yes, Indians can invest in the Aclaris Therapeutics (ACRS) from India.
With INDmoney, you can buy Aclaris Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Aclaris Therapeutics at zero transaction cost.
How can I buy Aclaris Therapeutics shares from India?
It is very easy to buy Aclaris Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Aclaris Therapeutics (ACRS) be purchased?
Yes, you can buy fractional shares of Aclaris Therapeutics with INDmoney app.
What are the documents required to start investing in Aclaris Therapeutics stocks?
To start investing in Aclaris Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What is Aclaris Therapeutics share price today?
Aclaris Therapeutics share price today stands at $1.31, Open: $1.33 ; Previous Close: $1.31 ; High: $1.33 ; Low: $1.28 ; 52 Week High: $5.17 ; 52 Week Low: $0.95.
The stock opens at $1.33, after a previous close of $1.31. The stock reached a daily high of $1.33 and a low of $1.28, with a 52-week high of $5.17 and a 52-week low of $0.95.
What are today’s High and Low prices of Aclaris Therapeutics Stock (ACRS)?
Today’s highest price of Aclaris Therapeutics (ACRS) is $1.33.
Today’s lowest price of Aclaris Therapeutics (ACRS) is $1.28.
What is the 52 Week High and Low Range of Aclaris Therapeutics Stock (ACRS)?
52 Week High
$5.17
52 Week Low
$0.95
What are the historical returns of Aclaris Therapeutics (ACRS)?
1 Month Returns
15.49%
3 Months Returns
-71.57%
1 Year Returns
9.66%
5 Years Returns
5.24%
What is today's market capitalisation of Aclaris Therapeutics?
Who is the Chief Executive Officer (CEO) of Aclaris Therapeutics ?
Discover More
- Ea Series Trust Intelligent Livermore Etf
$25.06
-0.67%
Paysign, Inc.$3.62
+0.42%
Zura Bio Ltd$1.08
-2.7%
- First Trust Alt Abs Ret Etf
$26.55
-1.65%
- Proshares Ultra Nasdaq Cybr
$56.78
+0.78%
Arbutus Biopharma Corporation$3.13
+1.62%
- Damon Inc
-76.0%
China Consumer Global X$22.24
+0.18%
Ishares Gen-immunology Hlth$19.74
-0.35%